Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France.
Anne AarninkJean David FumetLaure FavierCaroline TruntzerFrançois GhiringhelliPublished in: Journal of cancer research and clinical oncology (2020)
Our data support the hypothesis that pleuroperitoneal metastasis is a major predictive factor affecting CKI efficacy in NSCLC patients and may be used to avoid CKI monotherapy for such patients.